Functional quantification of cyclosporine A and FK506 in human whole blood by flow cytometry, using the green fluorescent protein as an interleukin-2 reporter gene

Journal of Immunological Methods

Volumn 256, Issue 1-2, 2001, Pages 77-87

  Taupin, Jean Luc ^a,b   Merville, Pierre ^b   McBride, Tarun ^a   Potaux, Luc ^b   Moreau, Jean François ^a,b  

^a CNRS Bordeaux Segalen University   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Cyclosporine A; FK506; Flow cytometry; Green fluorescent protein; Immunosuppression; Interleukin 2 promoter

Indexed keywords

ANTIBODY; CYCLOSPORIN A; GREEN FLUORESCENT PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; METHYLPREDNISOLONE SODIUM SUCCINATE; SANDIMMUM; TACROLIMUS; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BODY FLUID; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEVICE; DOSE RESPONSE; DRUG ACTIVITY; DRUG BLOOD LEVEL; EVALUATION; FLOW CYTOMETRY; FOLLOW UP; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPORTER GENE; REPRODUCIBILITY; T LYMPHOBLAST; TRANSPLANTATION;

ANTIBODIES, MONOCLONAL; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENES, REPORTER; GLUCOCORTICOIDS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; JURKAT CELLS; KIDNEY TRANSPLANTATION; LUMINESCENT PROTEINS; METHYLPREDNISOLONE; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; TACROLIMUS;

EID: 0035480096     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(01)00438-0     Document Type: Article

References (28)

1. Selective assay for CyPA and CyPB in human blood using highly specific antipeptide antibodies
2. The concentration-related distribution of cyclosporine in blood
3. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis
4. Regulation of the human interleukin-2 gene by the alpha and beta isoforms of the glucocorticoid receptor
5. Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients
6. Cyclosporine-treated renal transplant patients have only partial inhibition of calcineurin phosphatase activity
7. Evidence that calcineurin is rate-limiting for primary human lymphocyte activation
8. The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic ancephalomyelitis (EAE)
9. Minimizing cyclosporine concentration variability to optimize transplant outcome
10. Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine
11. Enhancing the effect of cyclophilin B on immunosuppressive activity of cyclosporine
12. Assessment of the biological activity of cyclosporine metabolites using the human JURKAT cell line
13. The temporal profile of calcineurin inhibition by cyclosporine in vivo
14. Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506
15. The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes
16. Negative regulation of interleukin 2 transcription by the glucocorticoid receptor
17. Monoclonal antibodies to cyclosporin are representative of the major populations present in antisera of immunized mice
18. Differences in type I and type II intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable allograft recipients
19. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): A critical overview of performance characteristics and comparison with HPLC
20. Advances in cyclosporine pharmacology, measurement, and therapeutic monitoring
21. Inhibitory effect of plasma FKBP12 on immunosuppressive activity of FK506
22. Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: How specific is specific?
23. Interaction of tacrolimus(FK506) and its metabolites with FKBP and calcineurin
24. The plasma FK506-binding protein 12 level is related to acute cellular rejection in small bowel transplantation
25. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements
26. Quantitation of immunosuppression by flow cytometry measurement of the capacity of T cells for interleukin-2 production
27. Detection and quantification of cyclosporine in body fluids using an interleukin-2 reporter-gene assay
28. Therapeutic monitoring of cyclosporine